Search

Rigel Pharmaceuticals Inc

Suletud

SektorTervishoid

40.02 2.17

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

38.68

Max

42.42

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+42.76% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

3. nov 2026

Uudiste sentiment

By Acuity

27%

73%

99 / 340 Pingereas Healthcare

Rigel Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. aug 2026, 23:01 UTC

News

Rigel Pharmaceuticals shares higher after reporting Q2 earnings of $0.88 and raising full-year sales guidance to $285 million to $295 million.

3. aug 2026, 19:26 UTC

Rigel Pharmaceuticals Inc. is higher today, aligning with market trends as the S&P 500 and Nasdaq see gains amid improved investor sentiment.

31. juuli 2026, 19:41 UTC

Rigel Pharmaceuticals is lower today amid significant downward pressure in the Biotechnology sub-sector, despite a slight recovery from session lows.

30. juuli 2026, 19:29 UTC

Rigel Pharmaceuticals Inc shares are lower today amid unusual volatility, reaching a session low earlier after peaking shortly after the market opened.

29. juuli 2026, 19:47 UTC

Rigel Pharmaceuticals Inc. is trading higher Wednesday, pulling back from earlier session highs amid mixed performance across major U.S. indices ahead of the Fed's decision.

28. juuli 2026, 19:56 UTC

News

Rigel Pharmaceuticals shares are higher today as the company announced a conference call for its second quarter 2026 financial results on August 4.

27. juuli 2026, 16:16 UTC

Rigel Pharmaceuticals is higher during Monday's session, rebounding after six days of declines. The stock remains up since Friday's close amid broader market dynamics.

24. juuli 2026, 20:01 UTC

Rigel Pharmaceuticals Inc shares are higher today, recovering from earlier dips amid increased trading volume and broader market gains despite no specific news identified.

22. juuli 2026, 20:06 UTC

Rigel Pharmaceuticals Inc shares are lower Wednesday amid ongoing market uncertainty ahead of the Federal Reserve meeting, with no specific news driving the decline.

21. juuli 2026, 17:26 UTC

News

Rigel Pharmaceuticals Inc shares are higher, reflecting positive sentiment in the biotechnology sector amid broader market gains, particularly in technology stocks.

Võrdlus sarnastega

Hinnamuutus

Rigel Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

42.76% tõus

12 kuu keskmine prognoos

Keskmine 55.25 USD  42.76%

Kõrge 81 USD

Madal 40 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Rigel Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

4 ratings

2

Osta

2

Hoia

0

Müü

Sentiment

By Acuity

99 / 340 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

$

help-icon Live chat